FDA Investigator Michael Y Philopoulos

Michael Y Philopoulos has conducted inspections on 15 sites in 2 countries as of 20 Nov 2019. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
15
Last Inspection Date:
20 Nov 2019
Investigator Role:
FDA Investigation Participant
Redica ID:
100005279
Countries of Inspections:
United States of America, Japan
FDA Investigators that have inspected at least one site in common with Michael Y Philopoulos:
Adaliz Santaliz Cruz, Adam J Wilson, Alexandra A Carrico, Amanda L Baskin, Amanda M Dunneback, Angel S Johnson, Anthony R Petriella, Azza Talaat, Barbara I Rogolsky, Bei Y He, Benjamin J Smith, Bing Lin, Brandi N Mcgrady, Brent M Dehaan, Brian D Garthwaite, Brian D Nicholson, Brittany A Mckenzie, Bruce H Mccullough, Byungja E Marciante, Carmen M Faraianu, Caroline H Le, Caroline Strasinger, Carrie Ann Plucinski, Catherine D Djordjevic, Charles L Zhou, Chase S Baldwin, Cheryl A Fuhs, Cheryl M Monroe, Christi L Bellmore, Christina A Miller, Christopher D Leach, Constantin Y Philopoulos, Corrine M Carter, Daniel B Arrecis, Daniel J Brown, Danny Tuntevski, Darren S Morgan, David L Duncan, David M Amy, David Perkins, Debra I Love, Denarvis C Mendenhall, Dr. Abhijit Raha, PhD, Elizabeth P Mayer, Emest F Bizjak, Emilie E Kahn, Emily E Krumel, Emily J Orban, Enrico Joset Mangahis, Eric S Pittman, Erin M Miller, Etty Feller, Evan M Kupper, Geneve M Maxwell, Geneve M Parks, Hassan M Fakhreddine, James P Stallings, Jayne E Holcomb, Jeffrey D Meng, Jennifer A Downie, Jennifer A Kemp, Joey V Quitania, Jorge F Christian, Joris Vanloco, Jose Acruz Gonzalez, José E Meléndez, Joseph A Piechocki, Joseph R Strelnik, Julia A Avery, Katherine Szestypalow, Kathryn G Brown, Kelley L Clark, L'oreal F Walker, Larry K Austin, Lauren E Burke, Leigh Anne Myers, Leslie A Paul, Lewis K Antwi, Libia M Lugo, Lindsey S Fleischman, Logan M Ebeling, Luis A Dasta, Lynda L Lanning, Margaret M Annes, Margaret N Persich, Martha Sullivan Myrick, Matt D Suedkamp, Matthew B Casale, Meisha R Sampson, Meisha Waters, Michele L Forster, PhD, Misty D Harvey, Nibin Varghese, MS, Nicholas F Lyons, Norman K Starks, Paranthaman Senthamaraikannan, Parul M Patel, Patricia A Cochran, Patricia H Dlugosz, Patsy J Domingo, Patty P Kaewussdangkul, Rabin N Ghoshal, Ralph A Erickson, Rebecca E Dombrowski, Regina T Brown, Robert G Taylor, Robert J Ham, Robert M Barbosa, Rohn R Robertson, Russell K Riley, Said H Muse, Sandra A Boyd, Sandra A Hughes, Sanket N Patel, Sarah E Rhoades, Sarah M Meng, Sarah M Napier, Sarah Nwandiuko, Sidney B Priesmeyer, Simone E Pitts, Sneha S Patel, Susan P Bruederle, Susanna E Ford, Suyang Qin, Tamayo C Barnes, Theodore N Sietsema, Timothy C Schell, Tonnie L Carter, Tracey Asinjen Wiersma, Tracey L Siebesma, William D Sherman, William D Tingley, William G Nelson, Yumi J Hiramine

Michael Y Philopoulos's Documents

Publish Date Document Type Title
June, 2016 EIR WelchDry Inc - EIR, 2016-06-28
August, 2018 FDA 483 Pet Apothecary Llc - Form 483, 2018-08-07
November, 2013 FDA 483 L. Perrigo Company - Form 483, 2013-11-07
November, 2013 EIR L. Perrigo Company - EIR, 2013-11-07
July, 2019 FDA 483 Medscript Compounding Pharmacy - Form 483, 2019-07-17
April, 2019 FDA 483 Response Pharmichem Testing Services - Form 483R, 2019-04-08
April, 2010 EIR Mead Johnson & Company, LLC - EIR, 2010-04-21
December, 2014 FDA 483 Coram Healthcare Corp. of Indiana - Form 483, 2014-12-16
June, 2012 FDA 483 Aurorium LLC - Form 483, 2012-06-15
November, 2014 FDA 483 Accra Pac, Inc. dba Voyant Beauty - Form 483, 2014-11-21
December, 2012 EIR WelchDry Inc - EIR, 2012-12-04
November, 2019 EIR Labcorp Drug Development Inc. - EIR, 2019-11-21
April, 2019 FDA 483 Pharmichem Testing Services - Form 483, 2019-04-03
April, 2019 EIR Pharmichem Testing Services - EIR, 2019-04-03
April, 2019 FDA 483 PQ Corporation - Form 483, 2019-04-16
April, 2019 EIR PQ Corporation - EIR, 2019-04-16
September, 2019 FDA 483 Otsuka Pharmaceutical Co Ltd - Form 483, 2019-09-10
July, 2014 FDA 483 Aurorium LLC - Form 483, 2014-07-11
October, 2010 FDA 483 Corium Innovations, Inc - Form 483, 2010-10-29

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more